ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2024

Nirsevimab to reduce infant morbidity from respiratory syncytial virus.

Bahaa Abu-Raya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.